Kathryn E. Wengel
Known title: DirectorCIK: 0001745955
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Transaction History
| JNJ | ▲ Buy | Option Exercise | 10,000 | $1.2M | 6/11/2026 | View on chart |
| JNJ | ▼ Sell | Open Market | 10,000 | $2.4M | 6/11/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 606 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 310 | $75K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 635 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 325 | $79K | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 6,414 | $1.6M | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 217 | $53K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 13,706 | $0 | 2/13/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 897 | — | 2/11/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 38,945 | $4.0M | 2/6/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 27,270 | $6.5M | 2/6/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 200 | $31K | 2/18/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 607 | $0 | 2/15/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 223 | $35K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,530 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 480 | $75K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 5,837 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 2,393 | $375K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 32,762 | $3.3M | 2/7/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 26,076 | $4.0M | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 944 | — | 2/6/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 651 | $0 | 2/13/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 333 | $53K | 2/13/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 11,826 | $0 | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,987 | $0 | 2/12/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 7,066 | $1.1M | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 35,638 | $3.2M | 2/9/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 27,333 | $4.3M | 2/9/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,971 | $0 | 2/8/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 1,009 | $158K | 2/8/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 947 | — | 2/7/2024 | View on chart |
| JNJ | ▼ Sell | Open Market | 12,465 | $2.0M | 6/12/2023 | View on chart |
| JNJ | ▲ Buy | Grant | 10,839 | $0 | 2/13/2023 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 4,891 | $792K | 2/13/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 742 | — | 2/11/2023 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,807 | $0 | 2/10/2023 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 667 | $108K | 2/10/2023 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 16,410 | $1.2M | 11/9/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 16,410 | $2.8M | 11/9/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 40,000 | $2.9M | 6/10/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 174 | $30K | 6/10/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 6,600 | $1.1M | 6/10/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 100 | $17K | 6/10/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 33,126 | $5.7M | 6/10/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 603 | — | 3/25/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 10,386 | $0 | 2/15/2022 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 4,699 | $780K | 2/15/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,896 | $0 | 2/14/2022 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 695 | $117K | 2/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JNJ Raises Sales Outlook Amid Dividend Focus
Johnson & Johnson has raised its sales outlook, reinforcing its status as a reliable dividend payer with a 3.12% yield. Recent coverage highlights the company's defensive qualities in volatile markets, noting its long history of increasing dividends. While the stock trades near its 52-week low, analysts maintain an average price target of $278.86, reflecting confidence in its ongoing performance.
JNJ Raises Sales Outlook Amid Dividend Focus. Johnson & Johnson has raised its sales outlook, reinforcing its status as a reliable dividend payer with a 3.12% yield. Recent coverage highlights the company's defensive qualities in volatile markets, noting its long history of increasing dividends. While the stock trades near its 52-week low, analysts maintain an average price target of $278.86, reflecting confidence in its ongoing performance.